Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
NCT ID:
NCT02107703
Group ID:
EG000
Title:
Abemaciclib + Fulvestrant
Description:
150 mg Abemaciclib given orally once every 12 hours in 28 day cycles. 500 mg fulvestrant administered as two 250-mg injections intramuscularly (IM) on Days 1 and 15 of Cycle 1, then on Day 1 of Cycle 2 and beyond. Participants may continue to receive treatment until discontinuation criteria are met.
Deaths Number Affected:
283
Deaths Number At Risk:
None
Serious Number Affected:
129
Serious Number At Risk:
441
Other Number Affected:
432
Other Number At Risk:
441
Study:
NCT02107703
Results Section:
NCT02107703
Adverse Events Module:
NCT02107703